Truong Lam Tuong

Dr. Truong Lam Tuong

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
NLNaphat Loeanurit
Naphat Loeanurit
TTTruong Lam Tuong
Truong Lam Tuong
VNVan Kieu Nguyen
Van Kieu Nguyen
VVVipanee Vibulakhaophan
Vipanee Vibulakhaophan
KHKowit Hengphasatporn
Kowit Hengphasatporn
SBSiwaporn Boonyasuppayakorn
Siwaporn Boonyasuppayakorn
Dengue is a mosquito-borne flavivirus that causes 21,000 deaths annually. Depsides and depsidones of lichens have previously been reported to be antimicrobials. In this study, our objective was to identify lichen-derived depsides and depsidones as dengue virus inhibitors. The 18 depsides and depsidones of Usnea baileyi, Usnea aciculifera, Parmotrema dilatatum, and Parmotrema tsavoense were tested against dengue virus serotype 2. Two depsides and one depsidone inhibited dengue virus serotype 2 without any apparent cytotoxicity. Diffractaic acid, barbatic acid, and Parmosidone C were three active compounds further characterized for their efficacies (EC50), cytotoxicities (CC50), and selectivity index (SI; CC50/EC50). Their EC50 (SI) values were 2.43 ± 0.19 (20.59), 0.91 ± 0.15 (13.33), and 17.42 ± 3.21 (8.95) μM, respectively. Diffractaic acid showed the highest selectivity index, and similar efficacies were also found in dengue serotypes 1–4, Zika, and chikungunya viruses. Cell-based studies revealed that the target was mainly in the late stage with replication and the formation of infectious particles. This report highlights that a lichen-derived diffractaic acid could become a mosquito-borne antiviral lead as its selectivity indices ranged from 8.07 to 20.59 with a proposed target at viral replication.

6 December 2025 in Journal of Theoretical Biology
Verified
Journal Article
Closed access
NDNguyen Dac-Nhan
Nguyen Dac-Nhan
QNQuoc-Thai Nguyen
Quoc-Thai Nguyen
TDThoai-My Dang
Thoai-My Dang
PTPhuong-Uyen Tran-Thi
Phuong-Uyen Tran-Thi
VTViet-Hung Tran
Viet-Hung Tran
Khac-Minh ThaiKhac-Minh Thai
Khac-Minh Thai

1 April 2026 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Khac-Minh ThaiKhac-Minh Thai
Khac-Minh Thai
CDCuong Quoc Duong
Cuong Quoc Duong
TMTan Mai
Tan Mai
TLTri Minh Le
Tri Minh Le
VTVan Thanh Tran
Van Thanh Tran
TTTruong Lam Tuong
Truong Lam Tuong
With the escalation of viral infections in recent decades, including the COVID- 19 pandemic, viral infectious diseases have increasingly become a global concern, attracting significant attention. Among many viral epidemics, the dengue virus, an RNA virus from the Flaviviridae family, has been reported by the WHO as one of the most prevalent mosquito-borne diseases, infecting roughly 400 million people yearly and spreading across all continents worldwide. In the last two decades, researchers from academia and industry have diligently studied many aspects of the virus, including its structure, life cycle, potential therapeutic agents, and vaccines. Dengvaxia® and Qdenga®, approved vaccines for DENV-4, have been a milestone in dengue prevention and treatment. However, these vaccines have some noticeable drawbacks, including Dengvaxia® being a monovalent vaccine against DENV-4 with a risk of severe dengue infection following the first use, Qdenga® being mainly effective for all 4 serotypes only in the cases of previously infected patients while being effective against only DENV-1 and DENV-2 in dengue-naïve patients. Additionally, no drug against dengue has been approved. Thus, numerous screening campaigns have been conducted on both natural and synthesized substances to search for anti-dengue agents, especially those targeting the virus's key protease (NS2B/NS3), to mitigate the dengue fever epidemic. As hit screening is only the first step in the drug discovery and development cycle, subsequent in-depth analyses (using a wide range of approaches from computational simulations to protein-ligand co-crystallization) have been conducted to provide more insights into the characteristics of optimal DENV NS2B/NS3 protease inhibitors. This review discusses recent discoveries in the search for novel inhibitors and highlights the importance of understanding the structural relationship between hits and the NS2B/NS3 protease for effective lead optimization.

11 July 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
TTTruong Lam Tuong
Truong Lam Tuong
CQCuong Quoc‐Duong
Cuong Quoc‐Duong
PHPhuong Nguyen Hoai‐Huynh
Phuong Nguyen Hoai‐Huynh
THThu Thi Hoai‐Nguyen
Thu Thi Hoai‐Nguyen
MKMinh Khac‐Thai
Minh Khac‐Thai
WCWarinthorn Chavasiri
Warinthorn Chavasiri


Verified
Journal Article
Open access
PDF file
HMHuynh Nhu Mai
Huynh Nhu Mai
DNDuc Kien Ngo
Duc Kien Ngo
MTManh Hung Tran
Manh Hung Tran
TNTuan Duc Nguyen
Tuan Duc Nguyen
HDHoang-Han Do
Hoang-Han Do
MLMinh-Quan Le
Minh-Quan Le
Chronic stress and anxiety highlight the need for safer natural alternatives to conventional therapies with severe adverse effects, yet the combined behavioral and biochemical effects of vitexin and its structural isomer, isovitexin, remain insufficiently investigated. This study evaluated the effects of a vitexin–isovitexin mixture in both crude and microencapsulated forms under acute and repeated restraint stress. In vitro radical-scavenging activity was assessed via the DPPH assay. In vivo, male Swiss albino mice subjected to acute (4 h) and repeated (4 h × 7 days) restraint stress received oral administration of the mixture (30 mg/kg) 30 min before each stress session, followed by behavioral testing and biochemical analysis; molecular docking was used as an exploratory approach to assess predicted structural compatibility with selected stress-related targets. In vitro, the mixture exhibited DPPH radical-scavenging activity. In vivo, the effects differed between the acute and repeated stress models, with significant changes in several behavioral outcomes, serum cortisol, and GSH levels, whereas MDA and TST responses were less consistent. Molecular docking suggested predicted structural compatibility of vitexin and isovitexin with SERT, 5-HT1A, GABAA, the glucocorticoid receptor, and Keap1. Overall, the VTX-iVTX mixture showed variable effects on stress-related behavioral and biochemical outcomes, with microencapsulation showing effects comparable to the crude form in most parameters and more pronounced effects in selected outcomes.